New Therapeutic Discovery Project Program will Support Research with Significant Potential to Produce new Therapies, Create High-Quality jobs
WASHINGTON--(BUSINESS WIRE)-- Today, Wednesday, November 3rd at 12:15 p.m. (EDT), Secretary of the Treasury Tim Geithner, Secretary of Health and Human Services Kathleen Sebelius, National Institutes of Health Director Francis Collins, and a business executive will hold a press conference call to announce new tax credits and grants that support groundbreaking biomedical research through the Affordable Care Act’s therapeutic discovery project program.
The therapeutic discovery project program is targeted to projects that show significant potential to produce new therapies, address unmet medical needs, reduce the long-term growth of health care costs and advance the goal of curing cancer within the next 30 years. These projects also have a great potential to create and sustain high-quality, high-paying jobs in the United States and to advance our competitiveness in the fields of life, biological, and medical sciences.
WHO: |
Secretary of the Treasury Tim Geithner |
|
Secretary of Health and Human Services Kathleen Sebelius | ||
National Institutes of Health Director Francis Collins | ||
CEO of Ligocyte Pharmaceuticals, Inc. Donald P. Beeman | ||
WHAT: |
Press conference call to roll out new Affordable Care Act tax credits and grants that support groundbreaking biomedical research through the Therapeutic Discovery Project Program |
|
WHEN: |
Wednesday, November 3rd at 12:15 p.m. (EDT) |
|
CALL IN: |
888-848-6507 |
|
PASSCODE: |
HHS |
|
Note: All HHS press releases, fact sheets and other press materials are available at http://www.hhs.gov/news.
CONTACT:
HHS Press Office
202-690-6343
KEYWORDS: United States North America District of Columbia
INDUSTRY KEYWORDS: Health Public Policy/Government Healthcare Reform Public Policy Professional Services Finance General Health
MEDIA:
Logo |